In this study, the role of retinoic inducible gene I (RIG-I)-mediated signalling in the inflammation of atherosclerosis was investigated to explain the pathology of atherosclerosis.
Introduction
Accumulating evidence suggests that inflammation plays an essential role in the pathogenesis of atherosclerosis. Clinical studies suggest that the inflammatory index, as measured by levels of C-reactive protein and cytokines, is an important independent predictor of the risk of atherosclerosis. 1 -3 The pro-inflammatory cytokines can be induced by different atherosclerotic risk factors, such as oxidized cholesterols, including 7-ketocholesterol, 7b-hydroxycholesterol, and 25-hydroxycholesterol (25HC). These compounds belong to a family of oxidized low-density lipoproteins that exert several pro-inflammatory effects leading to the development of coronary artery disease. 4 Oxysterols are thought to contribute to inflammation in atherosclerotic plaques. They are known as mediators of inflammation in endothelial cells and are known to induce expression of several chemokines, including interleukin-8 (IL-8). 5 Interleukin-8 is a pro-inflammatory chemokine. It has multiple biological functions during atherogenesis, including recruitment of neutrophils and T lymphocytes into the subendothelial space, 6, 7 monocyte adhesion to endothelium, and migration of vascular smooth muscle cells. 8, 9 Macrophage-derived human foam cells, which increase the instability of atherosclerotic plaque through inhibition of tissue inhibitor of metalloproteinase expression, contain high amounts of IL-8. 10, 11 Toll-like receptor (TLR) signalling contributes significantly to the inflammatory events of atherosclerosis. However, transfection of TLR-deficient human umbilical cord vein endothelial cells (HUVECs) with TLR1, 2, 4, or 6 did not increase sensitivity to 25-hydroxycholesterol. 12 Moreover, blockade of TLR2 or TLR4 with specific inhibitors did not reduce 25-hydroxycholesterolinduced IL-8 release from human acute monocytic leukemia cell line cells. 13 The underlying mechanism of induction of IL-8 by 25-hydroxycholesterol remains unknown.
Retinoic inducible gene I (RIG-I) is a recently identified caspase recruitment domain (CARD)-containing protein that functions as a cytoplasmic RNA sensor for viruses and induces type I interferon (IFN) through a TLR3-independent pathway. RIG-I contains an N-terminal CARD domain and a C-terminal DExD box RNA helicase domain.
14 The RIG-I downstream molecule, mitochondrial antiviralsignalling protein (MAVS; also known as IPS-1, VISA and Cardif), has been identified by different groups. 15 -18 It is located in the mitochondria, functions as a RIG-I adaptor, and also contains an N-terminal CARD-like domain and a C-terminal transmembrane domain. While RIG-I signalling in the anti-viral response is becoming clear, its other physiological functions are under-explored. We have previously reported that RIG-I plays a key role in the regulation of late-phase tumour necrosis factor-a expression in macrophages by lipopolysaccharide. 19 In the present study, we report that RIG-I signalling is essential for induction of IL-8 by 25-hydroxycholesterol. 
Methods

Reagents
Cell culture and transfection
Human umbilical cord vein endothelial cells were isolated as described by Jaffe et al. 20 Human umbilical cord veins were incubated with 0.2% collagenase for 15 min at 378C; the collagenase solution containing the endothelial cells was flushed from the cord by perfusion with 30 mL of cord buffer. 20 The effluent was collected in a 50 mL sterile conical centrifuge tube, and the cells were collected by sedimentation and cultured in medium 199 with 20% fetal bovine serum (FBS). Mouse peritoneal macrophages were obtained by lavage 4 days after the injection of sterile 3% thioglycolate broth. Cells were washed and suspended in RPMI 1640 medium containing 10% FBS and standard supplements. Primary macrophages were plated in 12-well culture plates. Cells were allowed to adhere, and monolayers were washed three times to remove nonadherent cells and incubated with RPMI 1640 medium containing 10% FBS 2 h after incubation. The wild-type and MAVS-deficient mouse embryo fibroblasts (MEFs) were generously provided by Dr. Z Chen (Zhijian Chen, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas). 16 JetPEI TM -HUVEC DNA transfection reagent (POLYPLUS-TRANSFECTION Inc., New York, NY, USA) was used for the transfection of HUVECs. The investigation of HUVECs conformed strictly with the principles outlined in the Declaration of Helsinki, 21 and was approved by the Applied Ethics Center of Peking University.
Animals and treatment
The C57BL6/J apolipoprotein E (apoE)-deficient and normal mice were purchased from the Department of Laboratory Animal Science of the Peking University Health Science Centre (Beijing, China 
Immunoblotting and ELISA
Cells were lysed with lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Nonidet p-40, 0.1 mg/mL leupeptin, 1 mM pheylmethylsulfonyl fluoride, and 1 mM sodium orthovanadate, pH 7.5). After centrifugation at 12 000 g for 20 min at 48C, the supernatant was collected and used for immunoblots. Cell medium was collected after treatment and subjected to an IL-8 ELISA kit (American Research Group Inc., Summerville, SC, USA).
Electrophoretic mobility shift assay
For the preparation of nuclear protein, cells were suspended in Buffer A (10 mM HEPES-KOH, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, and 0.5 mM leupeptin, pH 7.9) and incubated on ice for 10 min. Lysates were centrifuged at 7000 g for 10 min at 48C. Pellets were collected after centrifugation, and resuspended in Buffer B (20 mM HEPES-KOH, 25% glycerol, 1.5 mM MgCl 2 , 420 mM NaCl, 0.2 mM EDTA, 0.5 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, and 0.5 mM leupeptin, pH 7.9), and incubated on ice for 30 min followed by centrifugation at 15 000 g for 10 min at 48C. The supernatant was collected and stored as nuclear proteins. Oligonucleotide sequences for electrophoretic mobility shift assay (EMSA) were labelled by [g-32 P]ATP (Beifang Tongzheng Ltd, Beijing, China) with T4 polynucleotide kinase (NEB). EMSA was performed according to the method of Zhu et al. 23 The sequences of nuclear factor-kB (NF-kB), AP-1 and nuclear factor interleukin-6 (NF-IL-6) binding sites in IL-8 are listed the Supplementary material online (Table S1 ).
RNA silencing and quantitative PCR
For human RIG-I, double-stranded oligonucleotides corresponding to the target sequence of RIG-I cDNA were cloned into BglII and HindIII sites of pSUPER.retro.puro plasmid (OligoEngine). For MAVS and IRF1, short interfering RNA (siRNA) oligonucleotides targeting the respective cDNA were designed and synthesized by GenePharma (Shanghai, China). Lentiviral vector containing the targeting sequence (5 ′ -GCCCATTGAAACCAAGAAATT3-′ ) for RNA interference (RNAi) of mouse RIG-I was constructed as previously described. 19 Primary mouse macrophages were infected with concentrated lentiviral vector RIG-I signalling mediates IL-8 production in atherosclerosis stocks at a multiplicity of infection (moi) of 50-100 in the presence of 4 mg/mL polybrene. The sequences for siRNA are listed in the Supplementary material online ( 
Immunohistochemistry
For immunohistochemistry, the aortas of the apoE 2/2 mice were frozen in OCT compound, and sections at 7 mm intervals were cut at the origins of the aortic valve leaflets. The protocol for immunohistochemistry was performed as described previously. 24 The dilution of all the primary antibodies was as follows: CD31, 10 mg/mL; CD68, 10 mg/mL; and RIG-I, 20 mg/mL. All the second antibodies were diluted by 1:100.
Luciferase reporter assays
A reporter gene assay was performed using the dual luciferase system (Promega, Fitchburg, WI, USA). The total amount of plasmid for each transfection was adjusted with empty vector. Luciferase activity was measured 24 h after transfection, following the manufacturer's instructions. All reporter gene assays were repeated at least three times.
Statistical analysis
All data are shown as means + SEM. Analysis of variance (ANOVA) was followed by Newman-Keuls test to determine the statistical significance of differences between mean values. The computer program GraphPad Prism (GraphPad Software, Inc., San Diego, CA, USA) was used for statistical analysis. Differences were considered significant at P , 0.05.
Results
Co-induction of RIG-I and IL-8 by 25-hydroxycholesterol
Induction of RIG-I by different pathogens and cytokines suggests that RIG-I may be involved in several other cellular events besides anti-viral response. 19, 25, 26 As atherosclerosis has been considered an inflammatory disease, we explored whether RIG-I is induced during atherosclerosis. As an increased level of 25-hydroxycholesterol is a risk factor in atherosclerosis, 27, 28 we first examined the induction of RIG-I by 25-hydroxycholesterol in macrophages and endothelial cells. The results showed that RIG-I mRNA was induced in primary HUVECs as well as in macrophages following incubation of the cells with 25-hydroxycholesterol ( Figure 1A ). The induction of protein levels of RIG-I was confirmed by western blotting ( Figure 1B) . IL-8 up-regulation correlated with RIG-I at both mRNA and protein level ( Figure 1A and C ).
IRF1 mediates the expression of RIG-I by 25-hydroxycholestrol
To address how 25-hydroxycholestrol induces the expression of RIG-I, we tested whether 25-hydroxycholestrol could activate the RIG-I promoter with the reporters that we previously prepared. 25 The results showed that 25-hydroxycholestrol activated RIG-I promoter in a dose-dependent manner ( Figure 2A) . Interestingly, the 25-hydroxycholestrol activated RIG-I promoter was greatly repressed when the IFN regulatory factor 1 (IRF1) site was mutated. The mutations in IFN-sensitive response element (ISRE) and STAT1 sites had no effect ( Figure 2B ). These results indicate that IRF1 is the key transcription factor that drives the expression of RIG-I in response to 25-hydroxycholestrol stimulation. IRF1 was also induced by 25-hydroxycholestrol. The induction of IRF1 started at 1 h, and was earlier than RIG-I production ( Figure 2C ). We next addressed whether IRF1 was essential for 25-hydroxycholestrol induction of RIG-I. The induction of both RIG-I and IL-8 by 25-hydroxycholestrol were suppressed in HUVECs transfected with IRF1 siRNA ( Figure 2D ). 25-Hydroxycholestrol could induce both RIG-I and growth-regulated protein a (GRO-a) in wild-type macrophages. However, this induction was almost suppressed in IRF1 2/2 macrophages ( Figure 2E ).
These data demonstrate that IRF1 mediates 25-hydroxycholestrolinduced expression of RIG-I, as well as IL-8 and GRO-a.
RIG-I is required for the induction of IL-8 by 25-hydroxycholesterol
We next addressed whether RIG-I was required for the induction of IL-8 by 25-hydroxycholesterol. We knocked down RIG-I in HUVECs 
MAPKs mediate RIG-I signalling to drive the expression of IL-8
We further showed that MAVS-activated IL-8 promoter was much stronger than its upstream molecule, RIG-I ( Figure 4A ). The upstream region of the regulatory sequence of IL-8 contains several known cis-acting elements, including NF-kB, AP-1, and NF-IL-6, which are critical for the expression of IL-8. 23 , 29 The activation of IL-8 promoter by RIG-I active form CARD and MAVS was suppressed when each of these cis-acting elements was mutated ( Figure 4B ). These results suggest that MAVS was required for the activation of the transcription factors that activated the cis-acting elements in the IL-8 promoter.
We then tested whether 25-hydroxycholesterol activated NF-kB, AP-1, and NF-IL-6. As shown in Figure 4C , 25-hydroxycholesterol greatly induced the activation of transcription factors that bound cis-acting elements of NF-kB, AP-1, and NF-IL-6, respectively. (E) Peritoneal macrophages from IRF1 2/2 mice were isolated and stimulated with 25HC (5 mg/mL) for 16 h. Total RNA was extracted and subjected to q-PCR. *P , 0.05, **P , 0.01, ***P , 0.001. SV ¼ Sendai Virus. Furthermore, we showed that transfection of MAVS could also activate NF-kB, AP-1, and NF-IL-6 ( Figure 4D) . It has been known that RIG-I signalling activates NF-kB, but it is not clear whether this signalling activates AP-1 and NF-IL-6. AP-1 and NF-IL-6 are activated by MAPKs. 27 ,28 Therefore, we examined the effect of MAPK inhibitors on the activation of IL-8 by MAVS. Figure 4E shows that MAVS-induced expression of IL-8 was significantly suppressed in the presence of either JNK (SP60125) or ERK (U0126) inhibitors, but not in the presence of p38 inhibitor (SB503280). 25-Hydroxycholesterol-induced IL-8 mRNA was suppressed in the same manner ( Figure 4F ). Next we tested whether 25-hydroxycholesterol activated JNK and ERK through RIG-I signalling. Treatment of HUVECs with 25-hydroxycholesterol activated JNK and ERK, as well as p38 ( Figure 4G) . However, the activation status for p38 lasted only for a short time, about 2 h, while JNK and ERK remained activated for up to 24 h. Overexpression of MAVS activated JNK and ERK, but not p38 (data not shown). These results suggest that 25-hydroxycholesteroland MAVS-mediated IL-8 production required JNK and ERK activation. HUVECs were transfected with MAVS or control plasmid pcDNA3.1 for 24 h, and the nuclear protein was extracted and used for EMSA. (E) HUVECs were transfected with control plasmid pcDNA3.1 or MAVS for 24 h. Inhibitors for p38, JNK, and ERK were added at the same time.
RIG-I signalling mediates IL-8 production in atherosclerosis
Total RNA was extracted, followed by q-PCR assay. (F) HUVECs were pre-treated with different MAPK inhibitors (10 mM each) for 1 h. 25HC (5 mg/mL) was then added. Cells were cultured for another 24 h. Total RNA was extracted and q-PCR performed. (G) HUVECs were treated with 25HC (5 mg/mL) for different times. Total protein was extracted, followed by immunoblot assay. For all EMSAs, the concentration of the cold probe was 100 times greater than that of hot probe, and the first channel in each experiment was loaded with hot probe and bovine serum albumin as a control. *P , 0.05, **P , 0.01, ***P , 0.001.
TGF-b-activated kinase 1 is a downstream molecule of MAVS that induces the expression of IL-8
It has not yet been determined whether RIG-I signalling mediates the activation of MAPKs. It is known that TNF-a receptor associated factor 6 (TRAF6) associates with MAVS, and that TAK-1 can interact with TRAF6. TAK-1 is known to activate NF-kB, and MAPKs, including JNK, ERK, and p38. 29 -32 Therefore, we hypothesized that TAK-1 was a downstream molecule of MAVS to activate NF-kB, AP-1, and NF-IL-6. We found that over-expression of TAK-1 dominant negative form (TAK-1 DN) suppressed MAVS-activated IL-8 promoter, NF-kB, and AP-1 reporter ( Figure 5A ). TAK-1 alone also activated the IL-8 and AP-1 reporter ( Figure 5B ). TAK-1 directly induced the expression of IL-8 ( Figure 5C ). MAVS-induced expression of IL-8 was suppressed in the presence of the TAK-1 dominant negative form ( Figure 5D ). Furthermore, 25-hydroxycholesterol induced the expression of IL-8, which was also suppressed by the TAK-1 dominant negative form ( Figure 5E ). Finally, we showed that 25-hydroxycholesterol and MAVS induced the phosphorylation of TAK-1 ( Figure 5F and Supplementary material online, Figure S1) . These results clearly demonstrate that TAK-1 is a downstream molecule of MAVS to induce the expression of IL-8.
RIG-I and GRO-a are highly expressed in an atherosclerotic animal model
Finally, we examined whether the higher level of RIG-I appeared in the atherosclerotic model generated from apoE-deficient mice (apoE 2/2 ).
Arteries from apoE 2/2 mice were isolated and processed for immunohistochemistry. In addition, peritoneal macrophages were isolated to assess RIG-I expression levels. Lesion morphology was assessed in frozen aortic root sections of apoE-deficient mice. As shown in (Figure 6 ), RIG-I signal was remarkably stained in CD31-and CD68-positive cells in the lesion (Figure 6A ), suggesting that RIG-I was expressed in activated macrophages and endothelium within the lesion area. The mRNA expression of RIG-I and GRO-a, and the protein level of RIG-I were increased in peritoneal macrophages from apoE 2/2 mice, whereas all were undetectable in macrophages from normal mice ( Figure 6B ). Knock-down of RIG-I in apoE 2/2 macrophages by siRNA greatly suppressed the expression of GRO-a ( Figure 6C) . The co-induction of RIG-I with GRO-a strongly indicated the involvement of RIG-I in the development of atherosclerosis.
Discussion
It has been widely accepted that atherosclerosis results from hypercholesterolaemia and an inappropriate inflammatory response. The fact that peripheral blood mononuclear cells produce more IL-8 in hypercholesterolaemic patients was noticed many years ago. 33 Products of cholesterol oxidation accumulate in atherosclerotic plaques, and have been proposed to contribute to inflammatory signalling in the diseased artery. However, the underlying mechanism by which IL-8 was induced by increased cholesterol is largely unknown. Recent studies have shown that TLR signalling contributes significantly to the inflammatory events of atherosclerosis. 34 However, a line of evidence has demonstrated that cholesterol and oxysterols induce expression of various inflammatory genes, including IL-8, independent of TLR signalling. 13 In the present study, we identified that 25-hydroxycholesterol induces expression of RIG-I. IRF1 mediates the induction of RIG-I by 25-hydroxycholesterol. Induction of RIG-I by 25-hydroxycholesterol leads to the production of IL-8 in human cells and GRO-a in mouse macrophages. Cells knocked down for endogenous RIG-I are unable to induce the expression of IL-8 by 25-hydroxycholesterol, whereas over-expression of RIG-I leads to the production of IL-8. RIG-I-mediated IL-8 production requires the downstream signalling molecules, MAVS and TAK-1. 25-Hydroxycholesterol-induced GRO-a was suppressed in MAVSdeficient MEFs. TAK-1 activates the transcription factors NF-kB, AP-1, and NF-IL-6, leading to the expression of IL-8. It is interesting that although 25-hydroxycholesterol activates MAPK family members, including JNK, ERK, and p38, RIG-I signalling-induced expression of IL-8 requires JNK and ERK activity, not p38. Therefore, we reveal a novel role of RIG-I in atherosclerosis-associated inflammation. IRF1 has been known to play a role in the regulation of the induction of molecules that play important roles in inflammation, such as inducible nitric oxide synthase and IFNs. 35 , 36 Here we demonstrate that IRF1 is also involved in atherosclerosis-related inflammation. 25-Hydroxycholesterol induces IRF1, which subsequently leads to the induction of RIG-I and the inflammatory factor IL-8. Therefore, IRF1 is a key transcription factor in the regulation of RIG-I expression in atherosclerosis. In our study, up-regulation of RIG-I by 25-hydroxycholesterol resulted in the activation of NF-kB, AP-1, and NF-IL-6, and then led to the expression of pro-inflammatory genes, including IL-8, but not IFN-b. The expression of IFN-b requires the activation of IRF3, but 25-hydroxycholesterol does not activate IRF3 (data not shown). Under 25-hydroxycholesterol stimulation, the downstream pathway of RIG-I signalling to activate IRF3 is either blocked or not activated. This suggests that the regulation of the downstream molecules in the RIG-I pathway may be differentially regulated by different types of stimulation. Furthermore, RIG-I has been found to be induced by several inflammatory stimuli, and increased expression of RIG-I has been reported in various chronic inflammatory disorders, including rheumatoid arthritis and atherosclerosis. Collectively, these observations suggest that RIG-I may play a more important role in inflammation than in the anti-viral response. Insight into the mechanism of these novel roles for RIG-I could be very helpful to elucidate the role of RIG-I in biology and physiology. The high level of RIG-I protein in atherosclerotic plaque has been previously observed. Atherosclerotic plaque contains macrophages that sequentially become foam cells, and our data suggest that these macrophages produce IL-8 in a RIG-I-dependent manner. A scheme by which 25-hydroxycholesterol induces production of IL-8 via the IRF1/RIG-I axis is shown in Figure 6D .
In summary, the present study demonstrates that RIG-I plays a key role in inflammation associated with atherosclerosis. We hypothesize that RIG-I is a stress protein that mediates a wide range of inflammatory responses to microbial (virus and bacterial), cytokine (IFN-g) and pathological stimuli (oxidized cholesterol). The induction of RIG-I may lead to the sustained expression of pro-inflammatory genes, including IL-8, which results in the establishment of chronic inflammation. Therefore, targeting RIG-I signalling should have implications for the therapy of inflammation-related diseases, such as atherosclerosis, diabetes, and other cardiovascular diseases.
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